Added to YB: 2026-03-11
Pitch date: 2026-03-09
NRXS [neutral]
NeurAxis, Inc.
+19.83%
current return
Author Info
Schwar Capital is an investment firm with a newsletter that shares high-quality investing insights each week. Sign up for the newsletter.
Company Info
NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States.
Market Cap
$95.1M
Pitch Price
$5.75
Price Target
N/A
Dividend
N/A
EV/EBITDA
-13.66
P/E
-10.13
EV/Sales
20.65
Sector
Health Care Equipment and Supplies
Category
growth
15 Microcap Ideas on My Watchlist - NeurAxis, Inc.
NRXS (watchlist): IB-Stim device for pediatric functional abdominal pain cleared major hurdles—pediatric guidelines inclusion, Category 1 CPT code, major insurance coverage. Key question is scaling speed. Analyst models exclude VA revenue (double-digit $B TAM, equal to pediatric opportunity). If execution continues, NRXS dramatically underestimated as full TAM not modeled.
Read full article (1 min)